Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies

Focusing on data from the past five years, this review article takes a deep dive into systemic treatment for solid tumor bone metastasis, specifically decreasing dosing frequency of zoledronic acid in metastatic breast and prostate cancer and the use of radium-223 to treat metastatic prostate cancer.